Semiquantitative Analysis of Dopamine Transporter Scans in Patients with Parkinson Disease

Sule Tinaz, Christopher Chow, Phillip H Kuo, Elizabeth A Krupinski, Hal Blumenfeld, Elan D. Louis, George Zubal

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: Dopamine transporter (DaT) imaging is an adjunct diagnostic tool in parkinsonian disorders. Interpretation of DaT scans is based on visual reads. SBRquant is an automated method that measures the striatal binding ratio (SBR) in DaT scans, but has yet to be optimized. We aimed to (1) optimize SBRquant parameters to distinguish between patients with Parkinson disease (PD) and healthy controls using the Parkinson's Progression Markers Initiative (PPMI) database and (2) test the validity of these parameters in an outpatient cohort. Methods: For optimization, 336 DaT scans (215 PD patients and 121 healthy controls) from the PPMI database were used. Striatal binding ratio was calculated varying the number of summed transverse slices (N) and positions of the striatal regions of interest (d). The resulting SBRs were evaluated using area under the receiver operating characteristic curve. The optimized parameters were then applied to 77 test patients (35 PD and 42 non-PD patients). Striatal binding ratios were also correlated with clinical measures in the PPMI-PD group. Results: The optimal parameters discriminated the training groups in the PPMI cohort with 95.8% sensitivity and 98.3% specificity (lowest putamen SBR threshold, 1.037). The same parameters discriminated the groups in the test cohort with 97.1% sensitivity and 100% specificity (lowest putamen SBR threshold, 0.875). A significant negative correlation (r = -0.24, P = 0.0004) was found between putamen SBRs and motor severity in the PPMI-PD group. Conclusions: SBRquant discriminates DaT scans with high sensitivity and specificity. It has a high potential for use as a quantitative diagnostic aid in clinical and research settings.

Original languageEnglish (US)
Pages (from-to)e1-e7
JournalClinical Nuclear Medicine
Volume43
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Corpus Striatum
Dopamine Plasma Membrane Transport Proteins
Parkinson Disease
Putamen
Sensitivity and Specificity
Databases
Parkinsonian Disorders
ROC Curve
Outpatients
Research

Keywords

  • caudate
  • parkinsonism
  • putamen
  • SPECT imaging
  • striatal binding ratio

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Semiquantitative Analysis of Dopamine Transporter Scans in Patients with Parkinson Disease. / Tinaz, Sule; Chow, Christopher; Kuo, Phillip H; Krupinski, Elizabeth A; Blumenfeld, Hal; Louis, Elan D.; Zubal, George.

In: Clinical Nuclear Medicine, Vol. 43, No. 1, 01.01.2018, p. e1-e7.

Research output: Contribution to journalArticle

Tinaz, Sule ; Chow, Christopher ; Kuo, Phillip H ; Krupinski, Elizabeth A ; Blumenfeld, Hal ; Louis, Elan D. ; Zubal, George. / Semiquantitative Analysis of Dopamine Transporter Scans in Patients with Parkinson Disease. In: Clinical Nuclear Medicine. 2018 ; Vol. 43, No. 1. pp. e1-e7.
@article{c7602628a5d04f80b9dfc612a15a19ce,
title = "Semiquantitative Analysis of Dopamine Transporter Scans in Patients with Parkinson Disease",
abstract = "Purpose: Dopamine transporter (DaT) imaging is an adjunct diagnostic tool in parkinsonian disorders. Interpretation of DaT scans is based on visual reads. SBRquant is an automated method that measures the striatal binding ratio (SBR) in DaT scans, but has yet to be optimized. We aimed to (1) optimize SBRquant parameters to distinguish between patients with Parkinson disease (PD) and healthy controls using the Parkinson's Progression Markers Initiative (PPMI) database and (2) test the validity of these parameters in an outpatient cohort. Methods: For optimization, 336 DaT scans (215 PD patients and 121 healthy controls) from the PPMI database were used. Striatal binding ratio was calculated varying the number of summed transverse slices (N) and positions of the striatal regions of interest (d). The resulting SBRs were evaluated using area under the receiver operating characteristic curve. The optimized parameters were then applied to 77 test patients (35 PD and 42 non-PD patients). Striatal binding ratios were also correlated with clinical measures in the PPMI-PD group. Results: The optimal parameters discriminated the training groups in the PPMI cohort with 95.8{\%} sensitivity and 98.3{\%} specificity (lowest putamen SBR threshold, 1.037). The same parameters discriminated the groups in the test cohort with 97.1{\%} sensitivity and 100{\%} specificity (lowest putamen SBR threshold, 0.875). A significant negative correlation (r = -0.24, P = 0.0004) was found between putamen SBRs and motor severity in the PPMI-PD group. Conclusions: SBRquant discriminates DaT scans with high sensitivity and specificity. It has a high potential for use as a quantitative diagnostic aid in clinical and research settings.",
keywords = "caudate, parkinsonism, putamen, SPECT imaging, striatal binding ratio",
author = "Sule Tinaz and Christopher Chow and Kuo, {Phillip H} and Krupinski, {Elizabeth A} and Hal Blumenfeld and Louis, {Elan D.} and George Zubal",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/RLU.0000000000001885",
language = "English (US)",
volume = "43",
pages = "e1--e7",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Semiquantitative Analysis of Dopamine Transporter Scans in Patients with Parkinson Disease

AU - Tinaz, Sule

AU - Chow, Christopher

AU - Kuo, Phillip H

AU - Krupinski, Elizabeth A

AU - Blumenfeld, Hal

AU - Louis, Elan D.

AU - Zubal, George

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: Dopamine transporter (DaT) imaging is an adjunct diagnostic tool in parkinsonian disorders. Interpretation of DaT scans is based on visual reads. SBRquant is an automated method that measures the striatal binding ratio (SBR) in DaT scans, but has yet to be optimized. We aimed to (1) optimize SBRquant parameters to distinguish between patients with Parkinson disease (PD) and healthy controls using the Parkinson's Progression Markers Initiative (PPMI) database and (2) test the validity of these parameters in an outpatient cohort. Methods: For optimization, 336 DaT scans (215 PD patients and 121 healthy controls) from the PPMI database were used. Striatal binding ratio was calculated varying the number of summed transverse slices (N) and positions of the striatal regions of interest (d). The resulting SBRs were evaluated using area under the receiver operating characteristic curve. The optimized parameters were then applied to 77 test patients (35 PD and 42 non-PD patients). Striatal binding ratios were also correlated with clinical measures in the PPMI-PD group. Results: The optimal parameters discriminated the training groups in the PPMI cohort with 95.8% sensitivity and 98.3% specificity (lowest putamen SBR threshold, 1.037). The same parameters discriminated the groups in the test cohort with 97.1% sensitivity and 100% specificity (lowest putamen SBR threshold, 0.875). A significant negative correlation (r = -0.24, P = 0.0004) was found between putamen SBRs and motor severity in the PPMI-PD group. Conclusions: SBRquant discriminates DaT scans with high sensitivity and specificity. It has a high potential for use as a quantitative diagnostic aid in clinical and research settings.

AB - Purpose: Dopamine transporter (DaT) imaging is an adjunct diagnostic tool in parkinsonian disorders. Interpretation of DaT scans is based on visual reads. SBRquant is an automated method that measures the striatal binding ratio (SBR) in DaT scans, but has yet to be optimized. We aimed to (1) optimize SBRquant parameters to distinguish between patients with Parkinson disease (PD) and healthy controls using the Parkinson's Progression Markers Initiative (PPMI) database and (2) test the validity of these parameters in an outpatient cohort. Methods: For optimization, 336 DaT scans (215 PD patients and 121 healthy controls) from the PPMI database were used. Striatal binding ratio was calculated varying the number of summed transverse slices (N) and positions of the striatal regions of interest (d). The resulting SBRs were evaluated using area under the receiver operating characteristic curve. The optimized parameters were then applied to 77 test patients (35 PD and 42 non-PD patients). Striatal binding ratios were also correlated with clinical measures in the PPMI-PD group. Results: The optimal parameters discriminated the training groups in the PPMI cohort with 95.8% sensitivity and 98.3% specificity (lowest putamen SBR threshold, 1.037). The same parameters discriminated the groups in the test cohort with 97.1% sensitivity and 100% specificity (lowest putamen SBR threshold, 0.875). A significant negative correlation (r = -0.24, P = 0.0004) was found between putamen SBRs and motor severity in the PPMI-PD group. Conclusions: SBRquant discriminates DaT scans with high sensitivity and specificity. It has a high potential for use as a quantitative diagnostic aid in clinical and research settings.

KW - caudate

KW - parkinsonism

KW - putamen

KW - SPECT imaging

KW - striatal binding ratio

UR - http://www.scopus.com/inward/record.url?scp=85038599707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038599707&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001885

DO - 10.1097/RLU.0000000000001885

M3 - Article

VL - 43

SP - e1-e7

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 1

ER -